Eric S Daar

Title(s)Professor of Clinical , Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
    NIH R01MH110056Sep 23, 2015 - Jul 31, 2021
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2. bioRxiv. 2024 Aug 19. Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl DA, Currier JS, Daar ES, Greninger AL, Klekotka P, Grifoni A, Weiskopf D, Sette A, Peters B, Hughes MD, Chew KW, Smith DM, Crotty S, ACTIV-2/A5401 Study Team. PMID: 37961119; PMCID: PMC10634820.
      View in: PubMed   Mentions:
    2. Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2024 Aug 16; 230(2):394-402. Choudhary MC, Deo R, Evering TH, Chew KW, Giganti MJ, Moser C, Ritz J, Regan J, Flynn JP, Crain CR, Wohl DA, Currier JS, Eron JJ, Margolis D, Zhu Q, Zhon L, Ya L, Greninger AL, Hughes MD, Smith D, Daar ES, Li JZ. PMID: 38716969; PMCID: PMC11326811.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback. J Infect Dis. 2024 Jul 22. Bloom N, Ramirez SI, Cohn H, Parikh UM, Heaps A, Sieg SF, Greninger A, Ritz J, Moser C, Eron JJ, Bajic G, Currier JS, Klekotka P, Wohl DA, Daar ES, Li J, Hughes MD, Chew KW, Smith DM, Crotty S, Coelho CH, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team . PMID: 39036987.
      View in: PubMed   Mentions: 1     Fields:    
    4. Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial. J Infect Dis. 2024 Jul 20. Chew KW, Taiwo BO, Moser C, Daar ES, Wohl DA, Ritz J, Javan AC, Li JZ, Fischer W, Greninger AL, Bausch C, Luke T, Call R, Neytman G, Giganti MJ, Fletcher CV, Hughes MD, Eron JJ, Currier JS, Smith DM, ACTIV-2/A5401 Study Team . PMID: 39028902.
      View in: PubMed   Mentions:    Fields:    
    5. Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019. Clin Infect Dis. 2024 Jul 17. Jilg N, Giganti MJ, Chew KW, Shaw-Saliba K, Ritz J, Moser C, Evering TH, Daar ES, Eron JJ, Currier JS, Hughes MD, Lane HC, Dewar R, Smith DM, Li JZ. PMID: 39018444.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial. Pathog Immun. 2024; 9(1):138-155. Corado KC, Chew KW, Giganti MJ, Mu Y, Fletcher CV, Currier JS, Daar ES, Wohl DA, Li JZ, Moser CB, Ritz J, Javan AC, Neytman G, Caskey M, Hughes MD, Smith DM, Eron JJ, ACTIV-2/A5401 Study Team. PMID: 38746756; PMCID: PMC11093219.
      View in: PubMed   Mentions:
    7. Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. PLoS Pathog. 2024 Apr; 20(4):e1011680. Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS, ACTIV-2/A5401 Study Team. PMID: 38635853; PMCID: PMC11060554.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial. AIDS. 2024 07 01; 38(8):1141-1152. Crowell TA, Ritz J, Zheng L, Naqvi A, Cyktor JC, Puleo J, Clagett B, Lama JR, Kanyama C, Little SJ, Cohn SE, Riddler SA, Collier AC, Heath SL, Tantivitayakul P, Grinsztejn B, Arduino RC, Rooney JF, van Zyl GU, Coombs RW, Fox L, Ananworanich J, Eron JJ, Sieg SF, Mellors JW, Daar ES, AIDS Clinical Trials Group (ACTG) A5354/EARLIER Study Team. PMID: 38489580; PMCID: PMC11323228.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    9. Lymphocyte Count Derived Polygenic Score and Interindividual Variability in CD4 T-cell Recovery in Response to Antiretroviral Therapy. Pac Symp Biocomput. 2024; 29:594-610. Cardone KM, Dudek S, Keat K, Bradford Y, Cindi Z, Daar ES, Gulick R, Riddler SA, Lennox JL, Sinxadi P, Haas DW, Ritchie MD. PMID: 38160309; PMCID: PMC10764076.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback. bioRxiv. 2023 Nov 22. Coelho CH, Bloom N, Ramirez SI, Parikh UM, Heaps A, Sieg SF, Greninger A, Ritz J, Moser C, Eron JJ, Currier JS, Klekotka P, Wohl DA, Daar ES, Li J, Hughes MD, Chew KW, Smith DM, Crotty S, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. PMID: 38045374; PMCID: PMC10690233.
      View in: PubMed   Mentions:
    11. HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection. AIDS. 2024 03 15; 38(4):607-610. VanderVeen LA, Selzer L, Moldt B, Parvangada A, Li J, Ananworanich J, Crowell TA, Eron JJ, Daar ES, Haubrich R, Geleziunas R, Cyktor J, Mellors JW, Callebaut C. PMID: 38416554; PMCID: PMC10906214.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial. EClinicalMedicine. 2023 Nov; 65:102250. Jagannathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Main MJ, Monk PD, Javan AC, Li JZ, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W, ACTIV-2/A5401 Study Team. PMID: 37855026; PMCID: PMC10579289.
      View in: PubMed   Mentions: 3  
    13. One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial. Clin Infect Dis. 2023 10 05; 77(7):941-949. Jilg N, Chew KW, Giganti MJ, Daar ES, Wohl DA, Javan AC, Kantor A, Moser C, Coombs RW, Neytman G, Hoover K, Jana A, Hart PA, Greninger AL, Szurgot B, Eron JJ, Currier JS, Hughes MD, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37279602; PMCID: PMC10552586.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    14. Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation. AIDS. 2024 03 01; 38(3):317-327. Gandhi MM, Nguyen KL, Lake JE, Liao D, Khodabakhshian A, Guerrero M, Shufelt CL, Bairey Merz CN, Jordan WC, Daar ES, Bhattacharya D, Chew KW. PMID: 37788081; PMCID: PMC10841736.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus. Clin Infect Dis. 2023 09 18; 77(6):866-874. Letendre SL, Chen H, McKhann A, Roa J, Vecchio A, Daar ES, Berzins B, Hunt PW, Marra CM, Campbell TB, Coombs RW, Ma Q, Swaminathan S, Macatangay BJC, Morse GD, Miller T, Rusin D, Greninger AL, Ha B, Alston-Smith B, Robertson K, Paul R, Spudich S, A5324 Study Team. PMID: 37183889; PMCID: PMC10506779.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    16. Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. bioRxiv. 2023 Sep 17. Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS, ACTIV-2/A5401 Study Team. PMID: 37745410; PMCID: PMC10515893.
      View in: PubMed   Mentions:
    17. Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19. J Infect Dis. 2023 08 31; 228(Suppl 2):S117-S125. Giganti MJ, Chew KW, Eron JJ, Li JZ, Pinilla M, Moser C, Javan AC, Fischer WA, Klekotka P, Margolis D, Wohl DA, Coombs RW, Daar ES, Smith DM, Currier JS, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650230; PMCID: PMC10469105.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    18. Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials. J Infect Dis. 2023 08 31; 228(Suppl 2):S101-S110. Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Bender Ignacio R, Daar ES, Wohl DA, Currier JS, Eron JJ, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650235; PMCID: PMC10469328.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    19. Long COVID After Bamlanivimab Treatment. J Infect Dis. 2023 08 31; 228(Suppl 2):S126-S135. Evering TH, Moser CB, Jilg N, Yeh E, Sanusi B, Wohl DA, Daar ES, Li JZ, Klekotka P, Javan AC, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, ACTIV-2/A5401 Study Team. PMID: 37650236; PMCID: PMC10686694.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    20. Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial. J Infect Dis. 2023 08 31; 228(Suppl 2):S92-S100. Moser CB, Chew KW, Ritz J, Newell M, Javan AC, Eron JJ, Daar ES, Wohl DA, Currier JS, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650234; PMCID: PMC10686688.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    21. Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial. J Infect Dis. 2023 08 31; 228(Suppl 2):S83-S91. Chew KW, Moser C, Yeh E, Wohl DA, Daar ES, Ritz J, Javan AC, Eron JJ, Currier JS, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650237; PMCID: PMC10469584.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    22. ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients. J Infect Dis. 2023 08 31; 228(Suppl 2):S77-S82. Currier JS, Moser C, Eron JJ, Chew KW, Smith DM, Javan AC, Wohl DA, Daar ES, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650231; PMCID: PMC10469341.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    23. Immune Status and SARS-CoV-2 Viral Dynamics. J Infect Dis. 2023 08 31; 228(Suppl 2):S111-S116. Li Y, Moser C, Aga E, Currier JS, Wohl DA, Daar ES, Ritz J, Greninger AL, Sieg S, Parikh UM, Coombs RW, Hughes MD, Eron JJ, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37650232; PMCID: PMC10469582.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    24. Variant-Specific Viral Kinetics in Acute COVID-19. J Infect Dis. 2023 08 31; 228(Suppl 2):S136-S143. Ribeiro RM, Choudhary MC, Deo R, Giganti MJ, Moser C, Ritz J, Greninger AL, Regan J, Flynn JP, Wohl DA, Currier JS, Eron JJ, Hughes MD, Smith DM, Chew KW, Daar ES, Perelson AS, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37650233; PMCID: PMC10469346.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    25. Zinc and Coronavirus Disease 2019. Clin Infect Dis. 2023 08 22; 77(4):662. Swindells S, Eschenauer GA, Nason M, Daar ES. PMID: 37072885.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19. J Infect Dis. 2023 07 14; 228(2):133-142. Taiwo BO, Chew KW, Moser C, Wohl DA, Daar ES, Li JZ, Greninger AL, Bausch C, Luke T, Hoover K, Neytman G, Giganti MJ, Olefsky M, Javan AC, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM, ACTIV-2/A5401 Study Team. PMID: 36661240; PMCID: PMC10345463.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    27. Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption - Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence. AIDS Behav. 2023 Dec; 27(12):4041-4051. Wang Y, Daar ES, Huang Y, Xiong D, Shen J, Zhou L, Siqueiros L, Guerrero M, Rosen MI, Liu H. PMID: 37401993; PMCID: PMC10598162.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    28. Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19. Ann Intern Med. 2023 05; 176(5):658-666. Evering TH, Chew KW, Giganti MJ, Moser C, Pinilla M, Wohl DA, Currier JS, Eron JJ, Javan AC, Bender Ignacio R, Margolis D, Zhu Q, Ma J, Zhong L, Yan L, D'Andrea Nores U, Hoover K, Mocherla B, Choudhary MC, Deo R, Ritz J, Fischer WA, Fletcher CV, Li JZ, Hughes MD, Smith D, Daar ES, ACTIV-2/A5401 Study Team. PMID: 37068272; PMCID: PMC10150320.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    29. Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials. JAMA Netw Open. 2023 04 03; 6(4):e2310039. Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Aga E, Gibbs M, Tchouakam Kouekam H, Johnsson E, Esser MT, Hoover K, Neytman G, Newell M, Daar ES, Fischer W, Fletcher CV, Li JZ, Greninger AL, Coombs RW, Hughes MD, Smith D, Wohl DA, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)–2/A5401 Study Team. PMID: 37099295; PMCID: PMC10134004.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    30. Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials. medRxiv. 2023 Mar 17. Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Daar ES, Currier JS, Eron JJ, Smith DM, Hughes MD. PMID: 36993419; PMCID: PMC10055451.
      View in: PubMed   Mentions:
    31. Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection. Ann Intern Med. 2023 03; 176(3):348-354. Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 36802755; PMCID: PMC10052317.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    32. Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019. Clin Infect Dis. 2023 02 18; 76(4):734-737. Li Y, Harrison LJ, Chew KW, Currier JS, Wohl DA, Daar ES, Evering TH, Wu R, Giganti M, Ritz J, Javan AC, Coombs RW, Moser C, Hughes MD, Eron JJ, Smith DM, Li JZ. PMID: 36210483; PMCID: PMC9619579.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    33. Need for clear inclusion criteria in reviews of antiretroviral treatments - Authors' reply. Lancet HIV. 2023 03; 10(3):e150-e151. Gibas KM, Arribas JR, Cahn P, Daar ES, Taiwo BO. PMID: 36773626; PMCID: PMC10022476.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nat Commun. 2023 Jan 19; 14(1):333. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, ACTIV-2/A5401 Study Team, Hughes MD, Smith DM. PMID: 36658128; PMCID: PMC9851732.
      View in: PubMed   Mentions:    Fields:    
    35. Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials. Clin Transl Sci. 2023 03; 16(3):524-535. Mitjà O, Reis G, Boulware DR, Spivak AM, Sarwar A, Johnston C, Webb B, Hill MD, Smith D, Kremsner P, Curran M, Carter D, Alexander J, Corbacho M, Lee TC, Hullsiek KH, McDonald EG, Hess R, Hughes M, Baeten JM, Schwartz I, Metz L, Richer L, Chew KW, Daar E, Wohl D, Dunne M. PMID: 36601684; PMCID: PMC10014689.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight Gain. Pac Symp Biocomput. 2023; 28:233-244. Keat K, Hui D, Xiao B, Bradford Y, Cindi Z, Daar ES, Gulick R, Riddler SA, Sinxadi P, Haas DW, Ritchie MD. PMID: 36540980; PMCID: PMC10091400.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses. JCI Insight. 2022 12 22; 7(24). Ramirez SI, Grifoni A, Weiskopf D, Parikh UM, Heaps A, Faraji F, Sieg SF, Ritz J, Moser C, Eron JJ, Currier JS, Klekotka P, Sette A, Wohl DA, Daar ES, Hughes MD, Chew KW, Smith DM, Crotty S, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. PMID: 36378539; PMCID: PMC9869965.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    38. Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19. Open Forum Infect Dis. 2022 Nov; 9(11):ofac618. Moser C, Li JZ, Eron JJ, Aga E, Daar ES, Wohl DA, Coombs RW, Javan AC, Bender Ignacio RA, Jagannathan P, Ritz J, Sieg SF, Parikh UM, Hughes MD, Currier JS, Smith DM, Chew KW, ACTIV-2/A5401 Study Team . PMID: 36467293; PMCID: PMC9709705.
      View in: PubMed   Mentions: 6  
    39. Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial. EBioMedicine. 2022 Dec; 86:104330. Liu H, Wang Y, Huang Y, Xiong D, Shen J, Siqueiros L, Bala V, Savage GM, Guerrero M, Corado K, Rosen MI, Fletcher CV, Daar ES. PMID: 36372731; PMCID: PMC9782816.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    40. Two-drug regimens for HIV treatment. Lancet HIV. 2022 12; 9(12):e868-e883. Gibas KM, Kelly SG, Arribas JR, Cahn P, Orkin C, Daar ES, Sax PE, Taiwo BO. PMID: 36309038; PMCID: PMC10015554.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    41. Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial. Nat Microbiol. 2022 11; 7(11):1906-1917. Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes MD, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 36289399; PMCID: PMC9675946.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    42. Alterations of gray and white matter volumes and cortical thickness in treated HIV-positive patients. Magn Reson Imaging. 2023 01; 95:27-38. Joy A, Nagarajan R, Daar ES, Paul J, Saucedo A, Yadav SK, Guerrero M, Haroon E, Macey P, Thomas MA. PMID: 36265696.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. A community-partnered approach for diversity in COVID-19 vaccine clinical trials. J Clin Transl Sci. 2023; 7(1):e23. Castellon-Lopez Y, Landovitz R, Ntekume E, Porter C, Bross R, Hilder R, Lucas-Wright A, Daar ES, Chavez P, Blades C, Carson S, Morris D, Vassar S, Casillas A, Brown A. PMID: 36714798; PMCID: PMC9874035.
      View in: PubMed   Mentions: 4  
    44. Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nat Commun. 2022 08 22; 13(1):4931. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, ACTIV-2/A5401 Study Team, Hughes MD, Smith DM. PMID: 35995785; PMCID: PMC9395368.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    45. Burden of Hyperglycemia in Patients Receiving Corticosteroids for Severe COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2022 Oct; 6(5):484-487. Fetters KB, Judge SP, Daar ES, Hatlen TJ. PMID: 35966031; PMCID: PMC9359482.
      View in: PubMed   Mentions: 5  
    46. Viral and Symptom Rebound in Untreated COVID-19 Infection. medRxiv. 2022 Aug 02. Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 35982660; PMCID: PMC9387151.
      View in: PubMed   Mentions: 1  
    47. Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection. Cell Rep Med. 2022 07 19; 3(7):100678. Boucau J, Chew KW, Choudhary MC, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, POSITIVES study team, Li JZ, Barczak AK, ACTIV-2/A5401 Study Team. PMID: 35793677; PMCID: PMC9213028.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    48. High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I. AIDS. 2022 09 01; 36(11):1511-1520. Sax PE, Andreatta K, Molina JM, Daar ES, Hagins D, Acosta R, D'Antoni ML, Chang S, Martin R, Liu H, Blair C, McNicholl I, Gallant J, Collins SE, Martin H, White KL. PMID: 35466963; PMCID: PMC9451915.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    49. Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection. medRxiv. 2021 Dec 30. Boucau J, Chew KW, Choudhary M, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, Li JZ, Barczak AK, ACTIV-2/A5401 Study Team. PMID: 35018382; PMCID: PMC8750705.
      View in: PubMed   Mentions: 3  
    50. Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial. medRxiv. 2021 Dec 21. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs R, Ritz J, Giganti M, Javan AC, Li Y, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM, ACTIV-2/A5401 Study Team. PMID: 34981077; PMCID: PMC8722620.
      View in: PubMed   Mentions: 2  
    51. Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder. Clin Infect Dis. 2021 10 05; 73(7):e1982-e1990. Jacobs P, Feaster DJ, Pan Y, Gooden LK, Daar ES, Lucas GM, Jain MK, Marsh EL, Armstrong WS, Rodriguez A, Del Rio C, Metsch LR. PMID: 32569355; PMCID: PMC8492224.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    52. Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens. Clin Infect Dis. 2021 10 05; 73(7):e2153-e2163. Leonard MA, Cindi Z, Bradford Y, Bourgi K, Koethe J, Turner M, Norwood J, Woodward B, Erdem H, Basham R, Baker P, Rebeiro PF, Sterling TR, Hulgan T, Daar ES, Gulick R, Riddler SA, Sinxadi P, Ritchie MD, Haas DW. PMID: 32829410; PMCID: PMC8492125.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    53. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. N Engl J Med. 2021 12 16; 385(25):2348-2360. Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Guerreros Benavides A, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Brewinski Isaacs M, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A, AstraZeneca AZD1222 Clinical Study Group. PMID: 34587382; PMCID: PMC8522798.
      View in: PubMed   Mentions: 329     Fields:    Translation:HumansCellsCTClinical Trials
    54. Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy. medRxiv. 2021 Sep 15. Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes M, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 34545376; PMCID: PMC8452115.
      View in: PubMed   Mentions: 2  
    55. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 2021 08 12; 385(7):595-608. Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamaní J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B, HPTN 083 Study Team. PMID: 34379922; PMCID: PMC8448593.
      View in: PubMed   Mentions: 244     Fields:    Translation:HumansPHPublic Health
    56. Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation. Clin Infect Dis. 2021 08 02; 73(3):e643-e651. Crowell TA, Ritz J, Coombs RW, Zheng L, Eron JJ, Mellors JW, Dragavon J, van Zyl GU, Lama JR, Ruxrungtham K, Grinsztejn B, Arduino RC, Fox L, Ananworanich J, Daar ES, AIDS Clinical Trials Group A5354/EARLIER (Early ART to Limit Infection and Establishment of Reservoi. PMID: 33382405; PMCID: PMC8326583.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    57. Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19. Ann Intern Med. 2021 08; 174(8):1151-1158. Kuriakose S, Singh K, Pau AK, Daar E, Gandhi R, Tebas P, Evans L, Gulick RM, Lane HC, Masur H, NIH COVID-19 Treatment Guidelines Panel, Aberg JA, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio PS, Cantrill SV, Coopersmith CM, Davis SL, Dzierba AL, Gallagher JJ, Glidden DV, Grund B, Hardy EJ, Hinkson C, Hughes BL, Johnson S, Keller MJ, Kim AY, Lennox JL, Levy MM, Li JZ, Martin GS, Naggie S, Pavia AT, Seam N, Simpson SQ, Swindells S, Tien P, Waghmare AA, Wilson KC, Yazdany J, Zachariah P, Campbell DM, Harrison C, Burgess T, Francis J, Sheikh V, Uyeki TM, Walker R, Brooks JT, Ortiz LB, Davey RT, Doepel LK, Eisinger RW, Han A, Higgs ES, Nason MC, Crew P, Lerner AM, Lund C, Worthington C. PMID: 34125574; PMCID: PMC8252833.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsPHPublic Health
    58. Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults. PLoS Genet. 2021 04; 17(4):e1009464. Li B, Veturi Y, Verma A, Bradford Y, Daar ES, Gulick RM, Riddler SA, Robbins GK, Lennox JL, Haas DW, Ritchie MD. PMID: 33901188; PMCID: PMC8102009.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    59. Greater Levels of Self-Reported Adherence to Pre-Exposure Prophylaxis (PrEP) are Associated with Increased Condomless Sex Among Men Who Have Sex with Men. AIDS Behav. 2020 Nov; 24(11):3192-3204. Pasipanodya EC, Li MJ, Jain S, Sun X, Tobin J, Ellorin E, Dube M, Daar ES, Corado K, Milam J, Blumenthal J, Morris SH, Moore DJ, and the California Collaborative Treatment Group (CCTG). PMID: 32350774; PMCID: PMC7508761.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    60. Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S63-S69. Neilan TG, Nguyen KL, Zaha VG, Chew KW, Morrison L, Ntusi NAB, Toribio M, Awadalla M, Drobni ZD, Nelson MD, Burdo TH, Van Schalkwyk M, Sax PE, Skiest DJ, Tashima K, Landovitz RJ, Daar E, Wurcel AG, Robbins GK, Bolan RK, Fitch KV, Currier JS, Bloomfield GS, Desvigne-Nickens P, Douglas PS, Hoffmann U, Grinspoon SK, Ribaudo H, Dawson R, Goetz MB, Jain MK, Warner A, Szczepaniak LS, Zanni MV. PMID: 32645158; PMCID: PMC7347082.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    61. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature. 2020 08; 584(7822):614-618. Link JO, Rhee MS, Tse WC, Zheng J, Somoza JR, Rowe W, Begley R, Chiu A, Mulato A, Hansen D, Singer E, Tsai LK, Bam RA, Chou CH, Canales E, Brizgys G, Zhang JR, Li J, Graupe M, Morganelli P, Liu Q, Wu Q, Halcomb RL, Saito RD, Schroeder SD, Lazerwith SE, Bondy S, Jin D, Hung M, Novikov N, Liu X, Villaseñor AG, Cannizzaro CE, Hu EY, Anderson RL, Appleby TC, Lu B, Mwangi J, Liclican A, Niedziela-Majka A, Papalia GA, Wong MH, Leavitt SA, Xu Y, Koditek D, Stepan GJ, Yu H, Pagratis N, Clancy S, Ahmadyar S, Cai TZ, Sellers S, Wolckenhauer SA, Ling J, Callebaut C, Margot N, Ram RR, Liu YP, Hyland R, Sinclair GI, Ruane PJ, Crofoot GE, McDonald CK, Brainard DM, Lad L, Swaminathan S, Sundquist WI, Sakowicz R, Chester AE, Lee WE, Daar ES, Yant SR, Cihlar T. PMID: 32612233; PMCID: PMC8188729.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansCellsCTClinical Trials
    62. Perceptions of People Living with HIV and HIV Healthcare Providers on Real-Time Measuring and Monitoring of Antiretroviral Adherence Using Ingestible Sensors: A Qualitative Study. AIDS Res Treat. 2020; 2020:1098109. Kamal S, Rosen MI, Lazar C, Siqueiros L, Wang Y, Daar ES, Liu H. PMID: 32566285; PMCID: PMC7296466.
      View in: PubMed   Mentions: 9  
    63. Pharmacokinetics of Coencapsulated Antiretrovirals with Ingestible Sensors. AIDS Res Hum Retroviruses. 2020 01; 36(1):65-74. Liu H, Daar E, Wang Y, Siqueiros L, Campbell K, Shen J, Guerrero M, Ko MW, Xiong D, Dao J, Young T, Rosen M, Fletcher CV. PMID: 31516025; PMCID: PMC6944136.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    64. Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot Study. Clin Transl Sci. 2020 01; 13(1):189-194. Daar ES, Rosen MI, Wang Y, Siqueiros L, Shen J, Guerrero M, Xiong D, Dao J, Young T, Corado K, Fletcher CV, Liu H. PMID: 31536156; PMCID: PMC6951462.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    65. Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV. Int J STD AIDS. 2019 08; 30(9):891-901. Pan Y, Metsch LR, Gooden LK, Philbin MM, Daar ES, Douaihy A, Jacobs P, Del Rio C, Rodriguez AE, Feaster DJ. PMID: 31159715; PMCID: PMC6854613.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Clin Infect Dis. 2019 05 17; 68(11):1877-1886. Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH. PMID: 30219823; PMCID: PMC6522677.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    67. Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202. Antimicrob Agents Chemother. 2019 04; 63(4). Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Acosta EP, Mager DE, Morse GD, AIDS Clinical Trials Group Study A5202 Team. PMID: 30642925; PMCID: PMC6437535.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    68. Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2019 03 01; 80(3):358-366. Hulgan T, Ramsey BS, Koethe JR, Samuels DC, Gerschenson M, Libutti DE, Sax PE, Daar ES, McComsey GA, Brown TT. PMID: 30531304; PMCID: PMC6375746.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    69. Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data. J Acquir Immune Defic Syndr. 2019 03 01; 80(3):330-341. Nijhawan AE, Metsch LR, Zhang S, Feaster DJ, Gooden L, Jain MK, Walker R, Huffaker S, Mugavero MJ, Jacobs P, Armstrong WS, Daar ES, Sullivan M, Del Rio C, Halm EA. PMID: 30763292; PMCID: PMC6488219.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    70. Progressive brain atrophy in chronically infected and treated HIV+ individuals. J Neurovirol. 2019 06; 25(3):342-353. Nir TM, Jahanshad N, Ching CRK, Cohen RA, Harezlak J, Schifitto G, Lam HY, Hua X, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Singer EJ, Alger JR, Thompson PM, Navia BA, HIV Neuroimaging Consortium. PMID: 30767174; PMCID: PMC6635004.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    71. Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV. J Acquir Immune Defic Syndr. 2019 01 01; 80(1):e9-e13. Milam J, Jain S, Dubé MP, Daar ES, Sun X, Corado K, Ellorin E, Blumenthal J, Haubrich R, Moore DJ, Morris SR, CCTG Team. PMID: 30334877; PMCID: PMC6289757.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansPHPublic Health
    72. The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities. Clin Infect Dis. 2019 01 01; 68(1):146-149. Philbin MM, Feaster DJ, Gooden L, Duan R, Das M, Jacobs P, Lucas GM, Batey DS, Nijhawan A, Jacobson JM, Mandler R, Daar E, McMahon DK, Armstrong WS, Del Rio C, Metsch LR. PMID: 29920584; PMCID: PMC6293003.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    73. Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1. Emerg Infect Dis. 2018 12; 24(12). Hoenigl M, Jain S, Moore D, Collins D, Sun X, Anderson PL, Corado K, Blumenthal JS, Daar ES, Milam J, Dubé MP, Morris S, California Collaborative Treatment Group 595 Team. PMID: 30457536; PMCID: PMC6256399.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    74. Two-drug regimens for treatment of naïve HIV-1 infection and as maintenance therapy. Drug Des Devel Ther. 2018; 12:3731-3740. Corado KC, Caplan MR, Daar ES. PMID: 30464404; PMCID: PMC6219414.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    75. Antiretroviral switch studies do matter. Lancet HIV. 2018 10; 5(10):e546. Daar ES, Ruane P, DeJesus E, Stellbrink HJ, Molina JM. PMID: 30319119.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex With Men. J Infect Dis. 2018 10 05; 218(10):1551-1559. Pasipanodya EC, Jain S, Sun X, Blumenthal J, Ellorin E, Corado K, Dube MP, Daar ES, Morris SR, Moore DJ, California Collaborative Treatment Group (CCTG) TAPIR Study Team. PMID: 30295803; PMCID: PMC6455933.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    77. Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood. J Clin Pharmacol. 2018 12; 58(12):1604-1617. Yang J, Nikanjam M, Best BM, Pinto J, Chadwick EG, Daar ES, Havens PL, Rakhmanina N, Capparelli EV. PMID: 30252146; PMCID: PMC6604805.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    78. Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594. AIDS Behav. 2018 Aug; 22(8):2698-2710. Corado K, Jain S, Morris S, Dube MP, Daar ES, He F, Aldous JL, Sitapati A, Haubrich R, Milam J, Karris MY. PMID: 29725790; PMCID: PMC6599592.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. CD8+ Cytotoxic T Lymphocyte Responses and Viral Epitope Escape in Acute HIV-1 Infection. Viral Immunol. 2018 09; 31(7):525-536. Kim J, De La Cruz J, Lam K, Ng H, Daar ES, Balamurugan A, Yang OO. PMID: 30059271; PMCID: PMC6145043.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    80. Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics. 2018 07; 28(7):179-187. Haas DW, Bradford Y, Verma A, Verma SS, Eron JJ, Gulick RM, Riddler SA, Sax PE, Daar ES, Morse GD, Acosta EP, Ritchie MD. PMID: 29847509; PMCID: PMC6010221.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    81. Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2018 07; 5(7):e347-e356. Daar ES, DeJesus E, Ruane P, Crofoot G, Oguchi G, Creticos C, Rockstroh JK, Molina JM, Koenig E, Liu YP, Custodio J, Andreatta K, Graham H, Cheng A, Martin H, Quirk E. PMID: 29925490.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCellsCTClinical Trials
    82. Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav. 2018 Jun; 22(6):2026-2032. Winhusen T, Feaster DJ, Duan R, Brown JL, Daar ES, Mandler R, Metsch LR. PMID: 29030717; PMCID: PMC5899070.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    83. Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis. 2018 05 02; 66(10):1566-1572. Moore DJ, Jain S, Dubé MP, Daar ES, Sun X, Young J, Corado K, Ellorin E, Milam J, Collins D, Blumenthal J, Best BM, Anderson P, Haubrich R, Morris SR. PMID: 29228144; PMCID: PMC6248545.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansPHPublic Health
    84. Next generation fixed dose combination pharmacotherapies for treating HIV. Expert Opin Pharmacother. 2018 04; 19(6):589-596. Caplan MR, Daar ES, Corado KC. PMID: 29557204.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    85. Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights. J R Stat Soc Ser A Stat Soc. 2018 Oct; 181(4):1193-1209. Buchanan AL, Hudgens MG, Cole SR, Mollan KR, Sax PE, Daar ES, Adimora AA, Eron JJ, Mugavero MJ. PMID: 30555215; PMCID: PMC6289264.
      View in: PubMed   Mentions: 44  
    86. Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants. Ther Drug Monit. 2017 12; 39(6):596-603. Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Yang Y, Wilding GE, Morse GD. PMID: 29135907; PMCID: PMC5718358.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    87. Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants. J Infect Dis. 2017 09 01; 216(5):554-564. Mollan KR, Tierney C, Hellwege JN, Eron JJ, Hudgens MG, Gulick RM, Haubrich R, Sax PE, Campbell TB, Daar ES, Robertson KR, Ventura D, Ma Q, Edwards DRV, Haas DW, AIDS Clinical Trials Group. PMID: 28931220; PMCID: PMC5853681.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    88. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Lancet. 2017 Nov 04; 390(10107):2063-2072. Gallant J, Lazzarin A, Mills A, Orkin C, Podzamczer D, Tebas P, Girard PM, Brar I, Daar ES, Wohl D, Rockstroh J, Wei X, Custodio J, White K, Martin H, Cheng A, Quirk E. PMID: 28867497.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCTClinical Trials
    89. Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study. Clin Infect Dis. 2017 Jul 01; 65(1):6-12. Wyles D, Bräu N, Kottilil S, Daar ES, Ruane P, Workowski K, Luetkemeyer A, Adeyemi O, Kim AY, Doehle B, Huang KC, Mogalian E, Osinusi A, McNally J, Brainard DM, McHutchison JG, Naggie S, Sulkowski M, ASTRAL-5 Investigators. PMID: 28369210; PMCID: PMC6248627.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    90. Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):226-231. Raffi F, Orkin C, Clarke A, Slama L, Gallant J, Daar E, Henry K, Santana-Bagur J, Stein DK, Bellos N, Scarsella A, Yan M, Abram ME, Cheng A, Rhee MS. PMID: 28272164; PMCID: PMC5427981.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    91. Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study. Clin Infect Dis. 2017 Jun 01; 64(11):1612-1614. Parker RA, Rabideau DJ, Sax PE, Tierney C, Daar ES, Collier AC, Losina E, Freedberg KA. PMID: 28329243; PMCID: PMC5434358.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    92. Novel approaches to HIV therapy. F1000Res. 2017; 6:759. Daar ES. PMID: 28649373; PMCID: PMC5464215.
      View in: PubMed   Mentions: 1     Fields:    
    93. Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202. Pharmacogenet Genomics. 2017 03; 27(3):101-111. Verma A, Bradford Y, Verma SS, Pendergrass SA, Daar ES, Venuto C, Morse GD, Ritchie MD, Haas DW. PMID: 28099408; PMCID: PMC5285297.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    94. Emtricitabine + tenofovir alafenamide for the treatment of HIV. Expert Opin Pharmacother. 2017 Mar; 18(4):427-432. Corado KC, Daar ES. PMID: 28151023.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    95. HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen. HIV Clin Trials. 2017 03; 18(2):67-74. Karris MY, Jain S, Day TR, Pérez-Santiago J, Goicoechea M, Dubé MP, Sun X, Spina C, Daar ES, Haubrich RH, Morris S, California Collaborative Treatment Group (CCTG) 589 Study Team. PMID: 28134057; PMCID: PMC5613656.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    96. Condomless Sex With Virologically Suppressed HIV-Infected Individuals: How Safe Is It? JAMA. 2016 Jul 12; 316(2):149-51. Daar ES, Corado K. PMID: 27404181.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    97. Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. JAMA. 2016 Jul 12; 316(2):156-70. Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castellón PC, Tross S, Haynes LF, Douaihy A, Sorensen JL, Metzger DS, Mandler RN, Colfax GN, del Rio C. PMID: 27404184; PMCID: PMC5339876.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCells
    98. Randomized Controlled Trial of an Internet Application to Reduce HIV Transmission Behavior Among HIV Infected Men Who have Sex with Men. AIDS Behav. 2016 06; 20(6):1173-1181. Milam J, Morris S, Jain S, Sun X, Dubé MP, Daar ES, Jimenez G, Haubrich R, CCTG 592 Team. PMID: 26487300; PMCID: PMC4838553.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    99. Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue. J Acquir Immune Defic Syndr. 2016 06 01; 72(2):e48-50. Karris MY, Jain S, Bowman VQ, Rieg G, Goicoechea M, Dube MP, Kerkar S, Kemper C, Diamond C, Sun X, Daar ES, Haubrich RH, Morris S, California Collaborative Treatment Group (CCTG) 589 Study Team. PMID: 26977746; PMCID: PMC4867124.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    100. Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART. J Acquir Immune Defic Syndr. 2016 06 01; 72(2):133-7. Dan JM, Massanella M, Smith DM, Spina CA, Schrier R, Daar ES, Dube MP, Morris SR, Gianella S. PMID: 26818740; PMCID: PMC4868660.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    101. Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials. Clin Infect Dis. 2016 07 15; 63(2):268-80. Borges ÁH, Lundh A, Tendal B, Bartlett JA, Clumeck N, Costagliola D, Daar ES, Echeverría P, Gisslén M, Huedo-Medina TB, Hughes MD, Huppler Hullsiek K, Khabo P, Komati S, Kumar P, Lockman S, MacArthur RD, Maggiolo F, Matteelli A, Miro JM, Oka S, Petoumenos K, Puls RL, Riddler SA, Sax PE, Sierra-Madero J, Torti C, Lundgren JD. PMID: 27090986; PMCID: PMC6276924.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    102. Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial. Lancet HIV. 2016 Apr; 3(4):e158-65. Gallant JE, Daar ES, Raffi F, Brinson C, Ruane P, DeJesus E, Johnson M, Clumeck N, Osiyemi O, Ward D, Morales-Ramirez J, Yan M, Abram ME, Plummer A, Cheng AK, Rhee MS. PMID: 27036991.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCellsCTClinical Trials
    103. Implementation and Operational Research: The Navigation Program: An Intervention to Reengage Lost Patients at 7 HIV Clinics in Los Angeles County, 2012-2014. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):e44-50. Wohl AR, Dierst-Davies R, Victoroff A, James S, Bendetson J, Bailey J, Daar E, Spencer L, Kulkarni S, Pérez MJ. PMID: 26484741.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    104. Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy. BMC Infect Dis. 2016 Jan 25; 16:24. Gianella S, Ginocchio CC, Daar ES, Dube MP, Morris SR. PMID: 26809559; PMCID: PMC4727320.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    105. Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection. AIDS. 2016 Jan; 30(2):193-201. Vanpouille C, Introini A, Morris SR, Margolis L, Daar ES, Dube MP, Little SJ, Smith DM, Lisco A, Gianella S. PMID: 26558730; PMCID: PMC4862605.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    106. Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. Pharmacogenet Genomics. 2015 Sep; 25(9):450-61. Wanga V, Venuto C, Morse GD, Acosta EP, Daar ES, Haas DW, Li C, Shepherd BE. PMID: 26148204; PMCID: PMC4522226.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    107. Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. Sci Rep. 2015 Aug 24; 5:13179. Massanella M, Gianella S, Schrier R, Dan JM, Pérez-Santiago J, Oliveira MF, Richman DD, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR. PMID: 26299251; PMCID: PMC4547398.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    108. Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men. PLoS One. 2015; 10(6):e0130410. Gianella S, Smith DM, Daar ES, Dube MP, Lisco A, Vanpouille C, Margolis L, Haubrich RH, Morris SR. PMID: 26061824; PMCID: PMC4465639.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    109. Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s. J Acquir Immune Defic Syndr. 2015 Jun 01; 69(2):168-77. Longenecker CT, Kitch D, Sax PE, Daar ES, Tierney C, Gupta SK, McComsey GA, AIDS Clinical Trials Group Study A5224s Team. PMID: 26009829; PMCID: PMC4445470.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    110. A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:156-62. Moore BA, Rosen MI, Wang Y, Shen J, Ablondi K, Sullivan A, Guerrero M, Siqueiros L, Daar ES, Liu H. PMID: 25645326; PMCID: PMC4498993.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    111. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):29-35. Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, Singer EJ, Campbell TB, McMahon DD, Buchthal S, Cohen R, Yiannoutsos C, Letendre SL, Navia BA, HIV Neuroimaging Consortium. PMID: 25622053; PMCID: PMC4424074.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    112. A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens. J Comp Eff Res. 2015 Mar; 4(2):101-14. Broglio KR, Daar ES, Quintana M, Yuan Y, Kalsekar A, Spellberg B, Lewis RJ, Akker Dv, Detry MA, Le T, Berry SM. PMID: 25825840.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    113. Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols. Pharmacogenet Genomics. 2015 Feb; 25(2):51-9. Lehmann DS, Ribaudo HJ, Daar ES, Gulick RM, Haubrich RH, Robbins GK, de Bakker PI, Haas DW, McLaren PJ. PMID: 25461247; PMCID: PMC4387236.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    114. Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols. Open Forum Infect Dis. 2015 Jan; 2(1):ofu113. Moore CB, Verma A, Pendergrass S, Verma SS, Johnson DH, Daar ES, Gulick RM, Haubrich R, Robbins GK, Ritchie MD, Haas DW. PMID: 25884002; PMCID: PMC4396430.
      View in: PubMed   Mentions: 24  
    115. Individualized diagnosis interventions can add significant effectiveness in reducing human immunodeficiency virus incidence among men who have sex with men: insights from Southern California. Ann Epidemiol. 2015 Jan; 25(1):1-6. Khanna A, Goodreau SM, Wohlfeiler D, Daar E, Little S, Gorbach PM. PMID: 25453725; PMCID: PMC4255290.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    116. Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine. J Acquir Immune Defic Syndr. 2014 Sep 01; 67(1):36-44. Wyatt CM, Kitch D, Gupta SK, Tierney C, Daar ES, Sax PE, Ha B, Melbourne K, McComsey GA, AIDS Clinical Trials Group Study A5224s Team. PMID: 25117929; PMCID: PMC4134097.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    117. Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202. J Antimicrob Chemother. 2014 Dec; 69(12):3300-10. Venuto CS, Mollan K, Ma Q, Daar ES, Sax PE, Fischl M, Collier AC, Smith KY, Tierney C, Morse GD. PMID: 25159623; PMCID: PMC4228779.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    118. Modeling the impact of post-diagnosis behavior change on HIV prevalence in Southern California men who have sex with men (MSM). AIDS Behav. 2014 Aug; 18(8):1523-31. Khanna AS, Goodreau SM, Gorbach PM, Daar E, Little SJ. PMID: 24165985; PMCID: PMC4004722.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    119. Short communication: HIV-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencing. AIDS Res Hum Retroviruses. 2014 Aug; 30(8):806-11. Al-Mawsawi LQ, Wu NC, De La Cruz J, Shi VC, Wu TT, Daar ES, Lewis MJ, Yang OO, Sun R. PMID: 24914638; PMCID: PMC4118717.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    120. Antiretroviral therapy: treatment-experienced individuals. Infect Dis Clin North Am. 2014 Sep; 28(3):439-56. Calvo KR, Daar ES. PMID: 25151565.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    121. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann Intern Med. 2014 Jul 01; 161(1):1-10. Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbell TB, Sax PE, Gulick RM, Na L, O'Keefe L, Robertson KR, Tierney C. PMID: 24979445; PMCID: PMC4204642.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    122. Impaired Nef function is associated with early control of HIV-1 viremia. J Virol. 2014 Sep 01; 88(17):10200-13. Kuang XT, Li X, Anmole G, Mwimanzi P, Shahid A, Le AQ, Chong L, Qian H, Miura T, Markle T, Baraki B, Connick E, Daar ES, Jessen H, Kelleher AD, Little S, Markowitz M, Pereyra F, Rosenberg ES, Walker BD, Ueno T, Brumme ZL, Brockman MA. PMID: 24965469; PMCID: PMC4136354.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    123. Impact of randomized antiretroviral therapy initiation on glucose metabolism. AIDS. 2014 Jun 19; 28(10):1451-61. Erlandson KM, Kitch D, Tierney C, Sax PE, Daar ES, Melbourne KM, Ha B, McComsey GA. PMID: 24637543; PMCID: PMC4167596.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    124. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. Clin Infect Dis. 2014 Sep 15; 59(6):888-96. Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS. PMID: 24842909; PMCID: PMC4155445.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    125. Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction. J Virol. 2014 Jul; 88(14):7881-92. De La Cruz J, Vollbrecht T, Frohnen P, Ng HL, Daar ES, Yang OO, Lewis MJ. PMID: 24789790; PMCID: PMC4097801.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    126. Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. J Virol. 2014 Jul; 88(14):7818-27. Gianella S, Massanella M, Richman DD, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM, California Collaborative Treatment Group 592 Team. PMID: 24789781; PMCID: PMC4097769.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    127. Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial. Open Forum Infect Dis. 2014 Mar; 1(1):ofu003. Gupta SK, Kitch D, Tierney C, Daar ES, Sax PE, Melbourne K, Ha B, McComsey GA, AIDS Clinical Trials Group Study A5224s Team. PMID: 25734077; PMCID: PMC4324191.
      View in: PubMed   Mentions: 8  
    128. Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202. Pharmacogenet Genomics. 2014 Apr; 24(4):195-203. Johnson DH, Venuto C, Ritchie MD, Morse GD, Daar ES, McLaren PJ, Haas DW. PMID: 24557078; PMCID: PMC4059003.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    129. Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):167-74. McComsey GA, Kitch D, Sax PE, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Daar ES. PMID: 24121755; PMCID: PMC3943548.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    130. Factors associated with high transmission risk and detectable plasma HIV RNA in HIV-infected MSM on ART. Int J STD AIDS. 2014 Sep; 25(10):734-41. Blumenthal J, Haubrich R, Jain S, Sun X, Dube M, Daar E, Milam J, Morris S. PMID: 24452730; PMCID: PMC4303352.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    131. Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine. PLoS One. 2013; 8(12):e83514. Funderburg NT, Andrade A, Chan ES, Rosenkranz SL, Lu D, Clagett B, Pilch-Cooper HA, Rodriguez B, Feinberg J, Daar E, Mellors J, Kuritzkes D, Jacobson JM, Lederman MM. PMID: 24367599; PMCID: PMC3867440.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCellsCTClinical Trials
    132. Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine. Clin Infect Dis. 2014 Feb; 58(4):555-63. Smith KY, Tierney C, Mollan K, Venuto CS, Budhathoki C, Ma Q, Morse GD, Sax P, Katzenstein D, Godfrey C, Fischl M, Daar ES, Collier AC, AIDS Clinical Trials Group 5202 Study Team. PMID: 24253247; PMCID: PMC3905755.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    133. Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment. AIDS. 2013 Nov 13; 27(17):2725-34. Hua L, Andersen JW, Daar ES, Glesby MJ, Hollabaugh K, Tierney C. PMID: 23921611; PMCID: PMC4214386.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    134. Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202. HIV Clin Trials. 2013 Nov-Dec; 14(6):284-91. Grant PM, Tierney C, Budhathoki C, Daar ES, Sax PE, Collier AC, Fischl MA, Zolopa AR, Balamane M, Katzenstein D. PMID: 24334181; PMCID: PMC4060613.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    135. Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density. AIDS. 2013 Aug 24; 27(13):2069-79. Erlandson KM, Kitch D, Tierney C, Sax PE, Daar ES, Tebas P, Melbourne K, Ha B, Jahed NC, McComsey GA. PMID: 24384588; PMCID: PMC3966569.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    136. Virologic correlates of anti-CMV IgG levels in HIV-1-infected men. J Infect Dis. 2014 Feb 01; 209(3):452-6. Gianella S, Morris SR, Tatro E, Vargas MV, Haubrich RH, Daar ES, Dube MP, Richman DD, Little SJ, Smith DM. PMID: 23964106; PMCID: PMC3883163.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    137. Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization. J Virol. 2013 Oct; 87(20):11173-86. Sloan EA, Kearney MF, Gray LR, Anastos K, Daar ES, Margolick J, Maldarelli F, Hammarskjold ML, Rekosh D. PMID: 23926352; PMCID: PMC3807272.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    138. Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage Clin. 2013; 3:132-42. Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Alger JR, Singer E, Buchthal S, Toga AW, Navia B, Thompson PM, HIV Neuroimaging Consortium. PMID: 24179857; PMCID: PMC3791291.
      View in: PubMed   Mentions: 40     Fields:    
    139. Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248. J Infect Dis. 2013 Sep; 208(6):884-91. Andrade A, Rosenkranz SL, Cillo AR, Lu D, Daar ES, Jacobson JM, Lederman M, Acosta EP, Campbell T, Feinberg J, Flexner C, Mellors JW, Kuritzkes DR, AIDS Clinical Trials Group A5248 Team. PMID: 23801609; PMCID: PMC3749011.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCellsCTClinical Trials
    140. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J Neurovirol. 2013 Jun; 19(3):209-18. Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, Robertson K, Yiannoutsos C, Cohen RA, Navia B, HIV Neuroimaging Consortium. PMID: 23613008; PMCID: PMC3740160.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    141. Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men. Clin Infect Dis. 2013 Aug; 57(3):441-7. Gianella S, Smith DM, Vargas MV, Little SJ, Richman DD, Daar ES, Dube MP, Zhang F, Ginocchio CC, Haubrich RH, Morris SR, CCTG 592 Team. PMID: 23595831; PMCID: PMC3703105.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    142. Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies. Pain Med. 2013 Jul; 14(7):1039-47. Harrison T, Miyahara S, Lee A, Evans S, Bastow B, Simpson D, Gilron I, Dworkin R, Daar ES, Wieclaw L, Clifford DB, ACTG A5252 Team. PMID: 23565581; PMCID: PMC4207215.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    143. Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease. Antivir Ther. 2013; 18(3):399-408. Schackman BR, Haas DW, Becker JE, Berkowitz BK, Sax PE, Daar ES, Ribaudo HJ, Freedberg KA. PMID: 23264445; PMCID: PMC3744167.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    144. Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants. Pharmacogenet Genomics. 2012 Dec; 22(12):858-67. Holzinger ER, Grady B, Ritchie MD, Ribaudo HJ, Acosta EP, Morse GD, Gulick RM, Robbins GK, Clifford DB, Daar ES, McLaren P, Haas DW. PMID: 23080225; PMCID: PMC3614365.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    145. Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202. J Infect Dis. 2013 Feb 15; 207(4):604-11. McComsey GA, Daar ES, O'Riordan M, Collier AC, Kosmiski L, Santana JL, Fichtenbaum CJ, Fink H, Sax PE, Libutti DE, Gerschenson M. PMID: 23204164; PMCID: PMC3549598.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    146. Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202. J Infect Dis. 2013 Feb 01; 207(3):420-5. Ribaudo HJ, Daar ES, Tierney C, Morse GD, Mollan K, Sax PE, Fischl MA, Collier AC, Haas DW, DS Clinical Trials Group. PMID: 23148286; PMCID: PMC3537445.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    147. HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status. J Infect Dis. 2012 Dec 15; 206(12):1920-30. Mollan K, Daar ES, Sax PE, Balamane M, Collier AC, Fischl MA, Lalama CM, Bosch RJ, Tierney C, Katzenstein D, AIDS Clinical Trials Group Study A5202 Team. PMID: 23148287; PMCID: PMC3502379.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    148. Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. J Altern Complement Med. 2013 Apr; 19(4):334-40. Poland RE, Gertsik L, Favreau JT, Smith SI, Mirocha JM, Rao U, Daar ES. PMID: 23098696; PMCID: PMC3627430.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    149. Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents. J Acquir Immune Defic Syndr. 2012 Oct 01; 61(2):243-8. Tenckhoff S, Kaiser T, Bredeek F, Donfield S, Menius E, Lail A, Mössner J, Daar ES, Tillmann HL. PMID: 23007118; PMCID: PMC3548052.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    150. Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS. 2012 Jul 17; 26(11):1371-85. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Sax PE. PMID: 22546988; PMCID: PMC3560932.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    151. The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis. 2012 Jan 01; 205(1):87-96. Hogan CM, Degruttola V, Sun X, Fiscus SA, Del Rio C, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima KT, Kallungal B, Camp R, Morton T, Daar ES, Little S, A5217 Study Team. PMID: 22180621; PMCID: PMC3242744.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    152. Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. J Infect Dis. 2011 Oct 15; 204(8):1191-201. Sax PE, Tierney C, Collier AC, Daar ES, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Feinberg J, Tashima K, Murphy RL, Fischl MA, AIDS Clinical Trials Group Study A5202 Team. PMID: 21917892; PMCID: PMC3173503.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCellsCTClinical Trials
    153. Barriers and unmet need for supportive services for HIV patients in care in Los Angeles County, California. AIDS Patient Care STDS. 2011 Sep; 25(9):525-32. Wohl AR, Carlos JA, Tejero J, Dierst-Davies R, Daar ES, Khanlou H, Cadden J, Towner W, Frye D. PMID: 21774689.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    154. Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s. Clin Infect Dis. 2011 Jul 15; 53(2):185-96. McComsey GA, Kitch D, Sax PE, Tebas P, Tierney C, Jahed NC, Myers L, Melbourne K, Ha B, Daar ES. PMID: 21690627; PMCID: PMC3165963.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    155. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202. J Infect Dis. 2011 Jun 15; 203(12):1791-801. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P, Myers L, Melbourne K, Ha B, Sax PE. PMID: 21606537; PMCID: PMC3100514.
      View in: PubMed   Mentions: 200     Fields:    Translation:Humans
    156. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. J Neurovirol. 2011 Aug; 17(4):368-79. Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Paulose S, Gaugh M, Tripoli C, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CR, Navia B, HIV Neuroimaging Consortium. PMID: 21556960; PMCID: PMC4309645.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    157. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS. 2011 Mar 13; 25(5):625-33. Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B, HIV Neuroimaging Consortium. PMID: 21297425; PMCID: PMC4326227.
      View in: PubMed   Mentions: 218     Fields:    Translation:Humans
    158. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Ann Intern Med. 2011 Apr 05; 154(7):445-56. Daar ES, Tierney C, Fischl MA, Sax PE, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Pappa KA, Woodward WC, Patterson K, Bolivar H, Benson CA, Collier AC, AIDS Clinical Trials Group Study A5202 Team. PMID: 21320923; PMCID: PMC3430716.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansCells
    159. Behaviors of recently HIV-infected men who have sex with men in the year postdiagnosis: effects of drug use and partner types. J Acquir Immune Defic Syndr. 2011 Feb 01; 56(2):176-82. Gorbach PM, Weiss RE, Jeffries R, Javanbakht M, Drumright LN, Daar ES, Little SJ. PMID: 21119524; PMCID: PMC3023009.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    160. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis. 2011 Feb 15; 203(4):442-51. Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, Hecht R, Daar ES, Collier AC, Margolick J, Kilby JM, Routy JP, Conway B, Kaldor J, Levy J, Schooley R, Cooper DA, Altfeld M, Richman D, Connick E. PMID: 21245157; PMCID: PMC3071223.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCellsPHPublic Health
    161. Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia. AIDS Res Hum Retroviruses. 2011 Apr; 27(4):391-8. Yang OO, Daar ES, Ng HL, Shih R, Jamieson BD. PMID: 21087140; PMCID: PMC3101083.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    162. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7. International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC, Olender SA, Ostrowski M, Owen WF, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, et al. PMID: 21051598; PMCID: PMC3235490.
      View in: PubMed   Mentions: 697     Fields:    Translation:HumansCells
    163. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J Neurovirol. 2010 Nov; 16(6):435-44. Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R, Taylor M, Thompson P, Tate D, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B, HIV Neuroimaging Consortium. PMID: 20961212; PMCID: PMC4560459.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    164. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol. 2010 Aug; 84(15):7581-91. Miura T, Brumme ZL, Brockman MA, Rosato P, Sela J, Brumme CJ, Pereyra F, Kaufmann DE, Trocha A, Block BL, Daar ES, Connick E, Jessen H, Kelleher AD, Rosenberg E, Markowitz M, Schafer K, Vaida F, Iwamoto A, Little S, Walker BD. PMID: 20504921; PMCID: PMC2897600.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    165. Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200. J Acquir Immune Defic Syndr. 2010 Apr 01; 53(4):491-5. Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertora J, Patterson KB, Daar ES, Cavert W, Brizz B, ACTG A5200 Team of the ACTG. PMID: 20130470; PMCID: PMC3477637.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    166. Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients. AIDS. 2010 Mar 13; 24(5):707-16. Goicoechea M, Jain S, Bi L, Kemper C, Daar ES, Diamond C, Ha B, Flaherty J, Sun S, Richman D, Louie S, Haubrich R, California Collaborative Treatment Group. PMID: 20087154.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    167. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol. 2010 Feb; 16(1):25-32. Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B. PMID: 20113183; PMCID: PMC2995252.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCells
    168. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. N Engl J Med. 2009 Dec 03; 361(23):2230-40. Sax PE, Tierney C, Collier AC, Fischl MA, Mollan K, Peeples L, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Koletar SL, Johnson VA, Geiseler PJ, Daar ES, AIDS Clinical Trials Group Study A5202 Team. PMID: 19952143; PMCID: PMC2800041.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    169. Newer antiretroviral agents and how to use them. Curr Infect Dis Rep. 2009 Jul; 11(4):327-34. Kim HH, Daar ES. PMID: 19545503.
      View in: PubMed   Mentions:
    170. Cardiovascular, renal and liver events associated with human immunodeficiency virus type 1 infection and antiretroviral therapy. F1000 Med Rep. 2009 May 28; 1. Daar ES. PMID: 20948738; PMCID: PMC2924718.
      View in: PubMed   Mentions:
    171. Newer antiretroviral agents and how to use them. Curr HIV/AIDS Rep. 2009 May; 6(2):55-62. Kim HH, Daar ES. PMID: 19358775.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    172. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 2009 Apr 25; 387(1):98-108. Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. PMID: 19268337; PMCID: PMC4474533.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    173. Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS Patient Care STDS. 2008 Dec; 22(12):947-54. Rieg G, Lewis RJ, Miller LG, Witt MD, Guerrero M, Daar ES. PMID: 19072101; PMCID: PMC2929381.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCellsPHPublic Health
    174. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology. 2008 Dec; 48(6):1769-78. Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TM. PMID: 19026009; PMCID: PMC2645896.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansCells
    175. Emerging resistance profiles of newly approved antiretroviral drugs. Top HIV Med. 2008 Oct-Nov; 16(4):110-6. Daar ES. PMID: 18838744.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    176. Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance. AIDS. 2008 Apr 23; 22(7):835-9. Liu L, May S, Richman DD, Hecht FM, Markowitz M, Daar ES, Routy JP, Margolick JB, Collier AC, Woelk CH, Little SJ, Smith DM. PMID: 18427201; PMCID: PMC2716722.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    177. Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr. 2008 Apr 15; 47(5):639-43. Gorbach PM, Drumright LN, Javanbakht M, Pond SL, Woelk CH, Daar ES, Little SJ. PMID: 18285715; PMCID: PMC4153748.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    178. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection. Expert Opin Pharmacother. 2008 Apr; 9(5):687-700. Lagnese M, Daar ES. PMID: 18345948.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    179. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination. J Virol. 2008 Mar; 82(6):2784-91. Balamurugan A, Lewis MJ, Kitchen CM, Robertson MN, Shiver JW, Daar ES, Pitt J, Ali A, Ng HL, Currier JS, Yang OO. PMID: 18199650; PMCID: PMC2259011.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    180. Clinical presentation and diagnosis of primary HIV-1 infection. Curr Opin HIV AIDS. 2008 Jan; 3(1):10-5. Daar ES, Pilcher CD, Hecht FM. PMID: 19372938.
      View in: PubMed   Mentions: 21     Fields:    
    181. A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients. J Acquir Immune Defic Syndr. 2007 Dec 01; 46(4):433-42. Best BM, Goicoechea M, Witt MD, Miller L, Daar ES, Diamond C, Tilles JG, Kemper CA, Larsen R, Holland DT, Sun S, Jain S, Wagner G, Capparelli EV, McCutchan JA, Haubrich RH, California Collaborative Treatment Group 578 Study Team. PMID: 17786128.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    182. Platelet count is associated with plasma HIV type 1 RNA and disease progression. AIDS Res Hum Retroviruses. 2007 Oct; 23(10):1257-61. Rieg G, Yeaman M, Lail AE, Donfield SM, Gomperts ED, Daar ES, Hemophilia Growth and Development Study (HGDS). PMID: 17961113.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    183. Incorporating novel virologic tests into clinical practice. Top HIV Med. 2007 Aug-Sep; 15(4):126-9. Daar ES. PMID: 17720997.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    184. Baseline HIV type 1 coreceptor tropism predicts disease progression. Clin Infect Dis. 2007 Sep 01; 45(5):643-9. Daar ES, Kesler KL, Petropoulos CJ, Huang W, Bates M, Lail AE, Coakley EP, Gomperts ED, Donfield SM, Hemophilia Growth and Development Study. PMID: 17683002.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    185. Unprotected anal intercourse and substance use before and after HIV diagnosis among recently HIV-infected men who have sex with men. Sex Transm Dis. 2007 Jun; 34(6):401-7. Drumright LN, Strathdee SA, Little SJ, Araneta MR, Slymen DJ, Malcarne VL, Daar ES, Gorbach PM. PMID: 17091117.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    186. Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol. 2007 May; 18(5):1584-93. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S. PMID: 17429053.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    187. New approaches and resolve may define the future of the global HIV pandemic. Res Initiat Treat Action. 2007; 12(2):8-10. Daar ES. PMID: 17486706.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    188. Characteristics of recently HIV-infected men who use the Internet to find male sex partners and sexual practices with those partners. J Acquir Immune Defic Syndr. 2006 Dec 15; 43(5):582-7. Smith DM, Drumright LN, Frost SD, Cheng WS, Espitia S, Daar ES, Little SJ, Gorbach PM. PMID: 17019370.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    189. Epidemiologic investigation of a cluster of workplace HIV infections in the adult film industry: Los Angeles, California, 2004. Clin Infect Dis. 2007 Jan 15; 44(2):301-5. Taylor MM, Rotblatt H, Brooks JT, Montoya J, Aynalem G, Smith L, Kenney K, Laubacher L, Bustamante T, Kim-Farley R, Fielding J, Bernard B, Daar E, Kerndt PR. PMID: 17173235; PMCID: PMC6800099.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    190. Measuring below the bar: what is it telling us? AIDS. 2006 Nov 28; 20(18):2385-7. Daar ES. PMID: 17117026.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    191. Novel antiretroviral agents in HIV therapy. Curr Infect Dis Rep. 2006 Nov; 8(6):489-96. Reed C, Daar ES. PMID: 17064643.
      View in: PubMed   Mentions: 1  
    192. Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection. J Acquir Immune Defic Syndr. 2006 Nov 01; 43(3):344-50. Drumright LN, Little SJ, Strathdee SA, Slymen DJ, Araneta MR, Malcarne VL, Daar ES, Gorbach PM. PMID: 16980913.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansPHPublic Health
    193. Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity. AIDS. 2006 Oct 24; 20(16):2123-5. Barbour JD, Hecht FM, Little SJ, Markowitz M, Daar ES, Kelleher AD, Routy JP, Campbell TB, Rosenberg ES, Segal MR, Weidler J, Grant RM. PMID: 17053362.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    194. Hepatitis C infection in dialysis patients: a link to poor clinical outcome? Int Urol Nephrol. 2007; 39(1):247-59. Kalantar-Zadeh K, Daar ES, Eysselein VE, Miller LG. PMID: 17009087.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    195. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 2006 Nov 10; 355(1):1-5. Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman DD. PMID: 16962152.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    196. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis. 2006 Sep 15; 194(6):725-33. Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S, AIEDRP Network. PMID: 16941337.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    197. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006 Jun 12; 20(9):1295-302. Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, Diamond C, Tilles JG, Kemper CA, Larsen R, Goicoechea M, Haubrich RH. PMID: 16816559.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    198. Transmission behaviors of recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr. 2006 May; 42(1):80-5. Gorbach PM, Drumright LN, Daar ES, Little SJ. PMID: 16763494.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    199. Molecular analysis of HIV strains from a cluster of worker infections in the adult film industry, Los Angeles 2004. AIDS. 2006 Apr 04; 20(6):923-8. Brooks JT, Robbins KE, Youngpairoj AS, Rotblatt H, Kerndt PR, Taylor MM, Daar ES, Kalish ML. PMID: 16549978; PMCID: PMC6785735.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsPHPublic Health
    200. Human immunodeficiency virus and fertility care: embarking on a path of knowledge and access. Fertil Steril. 2006 Feb; 85(2):298-300; discussion 301. Daar ES, Daar JF. PMID: 16595202.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    201. Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression. J Infect Dis. 2005 Nov 01; 192(9):1597-605. Daar ES, Lynn HS, Donfield SM, Lail A, O'Brien SJ, Huang W, Winkler CA, Hemophilia Growth and Development Study. PMID: 16206074.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    202. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis. 2005 Aug; 46(2):290-300. Kalantar-Zadeh K, Miller LG, Daar ES. PMID: 16112048.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    203. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol. 2005 Aug; 79(16):10218-25. Frahm N, Adams S, Kiepiela P, Linde CH, Hewitt HS, Lichterfeld M, Sango K, Brown NV, Pae E, Wurcel AG, Altfeld M, Feeney ME, Allen TM, Roach T, St John MA, Daar ES, Rosenberg E, Korber B, Marincola F, Walker BD, Goulder PJ, Brander C. PMID: 16051815; PMCID: PMC1182636.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    204. Longitudinal analysis of CD8 T-cell responses to HIV and hepatitis C virus in a cohort of co-infected haemophiliacs. AIDS. 2005 Jul 22; 19(11):1135-43. Harcourt GC, Donfield S, Gomperts E, Daar ES, Goulder P, Phillips RE, Klenerman P, Hemophilia Growth and Development Study (HGDS). PMID: 15990566.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    205. HIV-1 pol replication capacity predicts disease progression. AIDS. 2005 Jun 10; 19(9):871-7. Daar ES, Kesler KL, Wrin T, Petropoulo CJ, Bates M, Lail A, Hellmann NS, Gomperts E, Donfield S, Hemophilia Growth and Development Study. PMID: 15905667.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    206. Primary human immunodeficiency virus type 1 infection. Curr HIV/AIDS Rep. 2005 Jun; 2(2):55-60. Soogoor M, Daar ES. PMID: 16091249.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    207. Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance. AIDS Res Hum Retroviruses. 2005 May; 21(5):343-57. Daar ES, Richman DD. PMID: 15929696.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    208. Strategies for initiating combination antiretroviral therapy. AIDS Patient Care STDS. 2005 Apr; 19(4):224-38. Tapper ML, Daar ES, Piliero PJ, Smith K, Steinhart C. PMID: 15857194.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    209. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005 May 01; 191(9):1410-8. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. PMID: 15809898.
      View in: PubMed   Mentions: 170     Fields:    Translation:HumansCells
    210. Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment. Curr Infect Dis Rep. 2005 Mar; 7(2):147-153. Soogoor M, Daar ES. PMID: 15727743.
      View in: PubMed   Mentions: 1  
    211. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol. 2005 Jan; 79(2):860-8. Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, Petropoulos CJ, Richman DD, Little SJ, Brown AJ. PMID: 15613314; PMCID: PMC538553.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    212. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis. 2005 Jan 01; 191(1):4-10. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES, Hemophilia Growth and Development Study. PMID: 15592996.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    213. Incidence of HIV superinfection following primary infection. JAMA. 2004 Sep 08; 292(10):1177-8. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ. PMID: 15353529.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    214. What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 2. AIDS Read. 2004 Sep; 14(9):487-98. Ruane PJ, Daar ES. PMID: 15457602.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    215. What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 1. AIDS Read. 2004 Aug; 14(8):421-6, 431-2, 434. Ruane PJ, Daar ES. PMID: 15338522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    216. Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J Virol. 2004 Jul; 78(13):7279-83. Sagar M, Kirkegaard E, Long EM, Celum C, Buchbinder S, Daar ES, Overbaugh J. PMID: 15194805; PMCID: PMC421693.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    217. Antiretroviral rounds. Putting resistance to work. AIDS Clin Care. 2004 Jul; 16(7):56, 60. Daar ES, Elion R. PMID: 15300926.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    218. Lack of effect of recombinant human growth hormone on the in vitro activities of antiretroviral drugs against human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2004 Jun; 48(6):2337-40. Wainberg MA, Brenner BG, Daar E, Gertner JM, Olivier C, Kenley S. PMID: 15155249; PMCID: PMC415577.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    219. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2004 Apr 01; 35(4):367-75. Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, Svanberg E, Serono 9037 Study Team. PMID: 15097153.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    220. Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection. J Virol. 2004 Mar; 78(5):2242-6. Leigh Brown AJ, Frost SD, Good B, Daar ES, Simon V, Markowitz M, Collier AC, Connick E, Conway B, Margolick JB, Routy JP, Corbeil J, Hellmann NS, Richman DD, Little SJ. PMID: 14963120; PMCID: PMC369210.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    221. Potency and durability of antiretroviral therapy. J Acquir Immune Defic Syndr. 2003 Oct 01; 34 Suppl 2:S111-7. Daar ES. PMID: 14703939.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    222. Antiretroviral resistance in clinical practice. J Int Assoc Physicians AIDS Care (Chic). 2003 Sep; 2 Suppl 1:S4-18. Daar ES. PMID: 14569655.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    223. Antiretroviral rounds. The when, why and how of switching. AIDS Clin Care. 2003 Jun; 15(6):58-9. Henry K, Daar ES. PMID: 12866482.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    224. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003 Feb 24; 163(4):457-60. Matetzky S, Domingo M, Kar S, Noc M, Shah PK, Kaul S, Daar E, Cercek B. PMID: 12588205.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    225. Improving adherence to antiretroviral therapy. AIDS Read. 2003 Feb; 13(2):81-2, 85-6, 88-90. Daar ES, Cohen C, Remien R, Sherer R, Smith K. PMID: 12645492.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    226. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis. 2003 Feb 15; 187(4):683-6. Leigh Brown AJ, Frost SD, Mathews WC, Dawson K, Hellmann NS, Daar ES, Richman DD, Little SJ. PMID: 12599087.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    227. Treatment of primary HIV infection. MedGenMed. 2002 Nov 15; 4(4):15. Daar ES. PMID: 12817211.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    228. Isolation and characterization of an infectious HIV type 1 molecular clone from a patient with primary infection. AIDS Res Hum Retroviruses. 2002 Oct 10; 18(15):1127-33. Takeuchi H, Suzuki Y, Tatsumi M, Hoshino H, Daar ES, Koyanagi Y. PMID: 12402946.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    229. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002 Aug 08; 347(6):385-94. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. PMID: 12167680.
      View in: PubMed   Mentions: 296     Fields:    Translation:HumansCells
    230. Identifying and managing morphologic complications of HIV and HAART. AIDS Read. 2002 Mar; 12(3):114-9, 124-5. Currier J, Carpenter C, Daar E, Kotler D, Wanke C. PMID: 11966241.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Eric's Networks
    Concepts (541)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (87)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California